Is Granules India Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Granules India Ltd (GRANULES.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Granules India Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Granules India Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Granules India Ltd?

Muslim investors may consider investing in Granules India Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Granules India Ltd classified as HALAL?

Musaffa determines the Shariah status of Granules India Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Granules India Ltd updated?

The Shariah compliance status of Granules India Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Granules India Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Granules India Ltd?

You can check the latest Shariah compliance status of Granules India Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GRANULES.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 16, 2026

Report Source: 2026 3rd Quarter Report

Granules India Ltd. Stock Analysis GRANULES.NS

India Health Care Small Cap Report: Q3, 2026

Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. The firm operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The firm has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The company produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. The company has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The firm sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. The company also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.

Key Statistics of Granules India Ltd (GRANULES.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹731.20₹748.80

Today's Open

₹739.75

Volume

659.54K

P/E Ratio (TTM)

36.33

52 Week Range

₹432.60₹761.40

Market Cap

174.34B

Avg. Volume

1.65M

Dividend Yield

0.20%

Financial Metrics & Statements of Granules India Ltd (GRANULES.NS)

FAQ's for Granules India Ltd (GRANULES.NS)

According to Musaffa’s Shariah screening methodology, Granules India Ltd (GRANULES.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.